340Basics

About 340Basics

Operating under the brand Nuvem, the company provides integrated pharmacy solutions tailored for non-profit healthcare organizations. The firm's history began in 2014, initially as three distinct brands: 340Basics, Assent, and Apovia. A significant milestone occurred in August 2023, when the three entities officially consolidated under the single Nuvem brand to offer a more comprehensive and streamlined experience. While specific founder details are not prominent post-rebrand, the company's direction is steered by a leadership team that includes CEO Matt Umscheid.

Nuvem's business is centered on the Federal 340B Drug Pricing Program, a government initiative that allows certain healthcare providers serving uninsured and low-income patients to purchase outpatient drugs at significantly reduced prices. The company's clients are these qualified healthcare providers, referred to as Covered Entities, which include community health centers, FQHCs, and Ryan White clinics. The business model is rooted in providing technology-enabled services that help these organizations manage their 340B programs, maintain compliance, and optimize financial performance. Revenue is generated by offering these specialized pharmacy management and consulting solutions through a Software-as-a-Service (SaaS) model.

The core service is a suite of cloud-based pharmacy solutions that facilitate every aspect of a 340B program. This includes a pharmacy claims administration platform that automates the processing of claims for drugs purchased under the program. Key features encompass managing in-house and contract pharmacy networks, ensuring program integrity through audits and compliance support, and utilizing advanced data analytics for better decision-making. By integrating these functions, Nuvem enables healthcare organizations to improve patient access to affordable medication, enhance operational efficiency, and increase savings, allowing them to focus more resources on patient care.